Tuberculosis in Obstetrics and Gynecology
Tuberculosis in Obstetrics and Gynecology
Tuberculosis in Obstetrics and Gynecology
Incidence
1% of the OPD patients in the developing world
Pathogenesis
Causative organism mycobacterium TB mostly
human type Genital TB is always secondary to primary infection ( lungs 50%, lymph nodes, urinary tract, bones and joints) The fallopian tubes are invariably the primary sites of pelvic TB from where secondary spread occurs to other genital organs.
Mode of spread
Blood stream 90%
Fallopian tubes
Commonest site ( nearly 100%) Bilateral affection Initial site submucosal layer of the ampullary part Infection spread medially destruction of the muscles fibrous tissue thickened calcified Infection spread inward swollen mucosa and destroyed fimbria are everted and abdominal ostium usually remains patent Elongated and distended distal tube give appearance of tobacco pouch Adhesions tubercles burst out (inward pyosalphinx and outward perisalphingitis)
the tubal epithelium within the hypertrophied myosalphinx. Etiology unknown Radiology small diverticulum Non specific for TB DD pelvic endometriosis
Uterus
60%
to the surface premenstrual After menstruation reinfection lesion in basal layer or from tubes. Endometrial ulcerations may lead to adhesion or synechia ashermans syndrome infertility, secondary amenorrhea or recurrent abortion
Cervix
5-15%
Ovary
30%
Pelvic peritoneum
Peritonitis 40-50%
2 types Wet type or exudative ascites with straw colored fluid in the peritoneal cavity, parietal and visceral peritoneum covered with numerous small tubercles Dry type or adhesive dense adhesions with the bowel loops, adhesions are due to the fibrosis when wet heals
Microscopic appearance
Typical for TB
cells ( langerhans), chronic inflammatory cells and epitheloid cells, surrounding a central area of caseation necrosis
Clinical features
History
Childbearing period
PMH- pulmonary TB in adolescence (10-20%) FH- positive
Asymptomatic
Incident findings while investigating for infertility or
DUB
Infertility Primary or secondary 70-80% Tubal blockage, synechia or ovulatory dysfunction Menstrual abnormalities Menorrhagia or irregular bleeding Amenorrhea or oligomenorrhae
anorexia, etc
Signs
PA normal Irregular tender mass Feel doughy due to matted intestines Ascites PV ulcers Thickened tubes in the lateral fornices
Differntial diagnosis
Pyogenic tubo-ovarian mass
Pelvic endometriosis
Adherent ovarian cyst
Investigation
Aim is to Identify the primary lesion Confirm the genital lesion
CBC
Mantoux test
CRX Diagnostic uterine curettage premenstruation
Laparoscopy
Treatment
General
Chemotherapy
Surgical
General
Acute pulmonary infection requires hospital
admission Pelvic infection doesnt require hospital admission Good healthy diet Use condom during intercourse to avoid the spread of infection
Chemotherapy
Initial phase isoniazid, rifampicin, pyranzinamide
and ethambutol are used for 2 months Continuation phase isoniazid and rifampicin for 4 months One year after treatment diagnostic endometrial curettage and bacteriology examination is done.
Drug
Daily dosing
Thrice-weekly dosing*
Adverse reactions
Isoniazid (INH)
5 mg/kg max. 300 mg Adults: 15 mg per kg Elevation of hepatic orally or IM enzyme levels, hepatitis, neuropathy, central nervous system effects
Rifampin (Rifadin)
Pyrazinamide
Adults: 10 mg per kg Orange discoloration orally or IV of secretions and urine, gastrointestinal tract upset, hepatitis, bleeding problems, flu-like symptoms, drug interactions, rash Adults: 50 to 70 mg Gastrointestinal tract per kg orally upset, hepatitis, hyperuricemia, arthralgias
Ethambutol (Myambutol)
Surgery
Indication 1. Unresponsiveness of active disease in spite of adequate anti- TB chemotherapy 2. TB pyosalpinx, ovarian abscess or pyometra 3. Persistent Menorrhagia or chronic pelvic pain causing functional impairment
Contraindications
1. 2. 3.
Presence of active TB in extra genital sites Favorable response to chemotherapy Accidently discovery of tubo-ovarian mass on laparotomy
given at full doses for at least 6 weeks prior to the surgery and even continued after the surgery. Type of surgery Total hysterectomy with bilateral salpingooophprectomy Young women preserve atleast one ovary and resection of the mass, drain the pyometra or repair of the fistula.
TB in pregnancy
Incidence - 1-2%, increase incidence in patients with
6.
7.
PMH or FH positive Low socio-economic status Area with high prevalence of TB HIV infection Alcohol addiction IV drug abuse DM, jejunoileal bypass, Underweight by >=15%
Diagnosis
Tuberculin skin test
Diagnostic bronchoscopy
PCR
Congenital TB
Rare
Associated with HIV 1. Lesion noted in first week of life 2. Infected maternal genital tract or placenta 3. Cavitating hepatic Granuloma dx by percutanous liver biopsy 4. No evidence of post natal transmission
Prognosis
Pregnancy has got no deleterious side effect on the
course of the disease nor has the disease got any adverse effect on the course of pregnancy. In active disease fetus maybe affected via transplacental or aspiration of the amniotic fluid Untreated patients
Management
Medical
asymptomatic INH 300mg/day + pyridoxine 50 mg/day start in first trimester and continue for 6-9 months Treatment same as for gynecology Surgery surgery should be avoided usually in pregnancy
Obstetric management
TB is not an indication for termination of pregnancy Obstetric management is same for any other pregnant
women Breast feeding No CI when women is on chemotherapy But avoided if infant is also on chemotherapy because of overdose Active lesions, it is CI as well as baby is isolated from the mother. Infant is given prophylactic INH 10-20 mg/day for 3 months along with BCG vaccination. Contraception for at least 2years after test results are negative.